ISDA

Deposition Date 2013-12-20

Release Date 2014-05-21

Last Version Date 2024-02-28

Entry Detail

PDB ID:

4O6E

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine Inhibitors of Erk2

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.95 Å

R-Value Free:

0.22

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 1
Gene (Uniprot):MAPK1
Chain IDs:A
Chain Length:368
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P28482 Pfam ID:PF00069 EC:2.7.11.24

Ligand Molecules

2SH

Primary Citation

Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2.

Blake, J.F, Gaudino, J.J, De Meese, J, Mohr, P, Chicarelli, M, Tian, H, Garrey, R, Thomas, A, Siedem, C.S, Welch, M.B, Kolakowski, G, Kaus, R, Burkard, M, Martinson, M, Chen, H, Dean, B, Dudley, D.A, Gould, S.E, Pacheco, P, Shahidi-Latham, S, Wang, W, West, K, Yin, J, Moffat, J, Schwarz, J.B.Show

Bioorg.Med.Chem.Lett. 24 2635 2639 (2014)

PMID: 24813737 DOI: 10.1016/j.bmcl.2014.04.068

Abstact

The discovery and optimization of a series of tetrahydropyridopyrimidine based extracellular signal-regulated kinase (Erks) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent and selective inhibition of Erk2 and knockdown of phospho-RSK levels in HepG2 cells and tumor xenografts.

Legend

Protein

Chemical

Disease

Primary Citation of related structures